Investors Are Overpaying for Teva’s Turnaround

It is possible to imagine a bright future at Teva Pharmaceutical Industries for the first time in quite a while. There is no great need to rush into the stock, however.


Vote on this story -->>>

Comments are closed.

this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami